Schaeverbeke, Jolien http://orcid.org/0000-0003-2257-0568
Celen, Sofie
Cornelis, Julie
Ronisz, Alicja
Serdons, Kim
Van Laere, Koen
Thal, Dietmar Rudolf
Tousseyn, Thomas
Bormans, Guy
Vandenberghe, Rik
Article History
Received: 23 July 2019
Accepted: 18 November 2019
First Online: 18 December 2019
Compliance with ethical standards
:
: RV has been PI for [<sup>18</sup>F]MK6240 phase 1 and [<sup>18</sup>F]flutemetamol phase 1 & 2 trials. UZ/KU Leuven has MTAs wit RV as PI, with Avid Radiopharmaceuticals, Merck, and Tohoku University. UZ/KU Leuven has current clinical trial agreements with RV as PI with AbbVie, Biogen, EliLilly, Genentech and Roche. RV is a DSMB member of AC Immune phase 2 trial. DRT received consultant honorary from GE-Healthcare (UK), and Covance Laboratories (UK), speaker honorary from Novartis Pharma AG (Switzerland), travel reimbursement from GE-Healthcare (UK) and UCB (Belgium) and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium). GB collaborated with Janssen (Belgium), Merck (USA), UCB (Belgium), Celgene (USA), Takeda (USA), and Eikonizo (USA). KVL has performed consultancy services and contract research, through KU Leuven, during the past 5 years for GE Healthcare, Merck Inc., Janssen Pharmaceuticals, UCB, Novartis, Syndesi Therapeutics, Curasen, and Eikonizo. JS, SC, JC, AR, KS and TT have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individuals or their spouses for brain donation.